Use of diltiazem for treating retinal pathologies
US6716835B1 · kind B1 · utility
9Cited by
0References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 8, 2001 |
| Grant date | Apr 6, 2004 |
| Priority date | — |
| Expiry date | Jun 8, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns the use of a calcium channel blocker compound and/or cyclic GMP-dependent channels, namely diltiazem, for treating retinal pathologies, and more particularly retinal diseases caused by degeneration of visual receptors, in a human or animal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.